Amelanotic cutaneous melanoma

Case reports and considerations

R. Betti, R. Vergani, M. Palvarini, E. Inselvini, C. Pazzini, C. Crosti

Research output: Contribution to journalArticle

Abstract

In our study, we investigated the history of ten patients with amelanotic melanomas and considered the clinical aspect of the lesions and the difficulty in diagnosis, in order to discuss the possible delay in their diagnosis. The tumours regarded elderly patents (mean age 57.9 years), without significant difference betWeen sexes. Lower limbs were the preferential site (80%), the mean thickness was 2.9 min. We also found an average of 15.9 months of delay in diagnosis (vs 8 months in patients with pigmented melanoma). Amelanotic melanoma is easily confused with epithelial tumour or dermatitis, but when a lesion cannot be included among any usual presentations of the former, and does not respond to the routine treatment, the diagnosis of amelanotic melanoma should be taken into account. Moreover, the delay in diagnosis may contribute to the thickness of the tumour and to the poor prognosis.

Original languageEnglish
Pages (from-to)9-20
Number of pages12
JournalSkin Cancer
Volume14
Issue number1
Publication statusPublished - 1999

Fingerprint

Amelanotic Melanoma
Skin
Neoplasms
Patents
Dermatitis
Sex Characteristics
Lower Extremity
Melanoma
History

Keywords

  • Amelanotic melanoma
  • Delayed diagnosis

ASJC Scopus subject areas

  • Dermatology
  • Oncology

Cite this

Betti, R., Vergani, R., Palvarini, M., Inselvini, E., Pazzini, C., & Crosti, C. (1999). Amelanotic cutaneous melanoma: Case reports and considerations. Skin Cancer, 14(1), 9-20.

Amelanotic cutaneous melanoma : Case reports and considerations. / Betti, R.; Vergani, R.; Palvarini, M.; Inselvini, E.; Pazzini, C.; Crosti, C.

In: Skin Cancer, Vol. 14, No. 1, 1999, p. 9-20.

Research output: Contribution to journalArticle

Betti, R, Vergani, R, Palvarini, M, Inselvini, E, Pazzini, C & Crosti, C 1999, 'Amelanotic cutaneous melanoma: Case reports and considerations', Skin Cancer, vol. 14, no. 1, pp. 9-20.
Betti R, Vergani R, Palvarini M, Inselvini E, Pazzini C, Crosti C. Amelanotic cutaneous melanoma: Case reports and considerations. Skin Cancer. 1999;14(1):9-20.
Betti, R. ; Vergani, R. ; Palvarini, M. ; Inselvini, E. ; Pazzini, C. ; Crosti, C. / Amelanotic cutaneous melanoma : Case reports and considerations. In: Skin Cancer. 1999 ; Vol. 14, No. 1. pp. 9-20.
@article{f3f23762070c45389c6273a081ac5b3c,
title = "Amelanotic cutaneous melanoma: Case reports and considerations",
abstract = "In our study, we investigated the history of ten patients with amelanotic melanomas and considered the clinical aspect of the lesions and the difficulty in diagnosis, in order to discuss the possible delay in their diagnosis. The tumours regarded elderly patents (mean age 57.9 years), without significant difference betWeen sexes. Lower limbs were the preferential site (80{\%}), the mean thickness was 2.9 min. We also found an average of 15.9 months of delay in diagnosis (vs 8 months in patients with pigmented melanoma). Amelanotic melanoma is easily confused with epithelial tumour or dermatitis, but when a lesion cannot be included among any usual presentations of the former, and does not respond to the routine treatment, the diagnosis of amelanotic melanoma should be taken into account. Moreover, the delay in diagnosis may contribute to the thickness of the tumour and to the poor prognosis.",
keywords = "Amelanotic melanoma, Delayed diagnosis",
author = "R. Betti and R. Vergani and M. Palvarini and E. Inselvini and C. Pazzini and C. Crosti",
year = "1999",
language = "English",
volume = "14",
pages = "9--20",
journal = "Skin Cancer",
issn = "0871-2549",
publisher = "Revismedica - Revistas Medicas e Congressos Lda.",
number = "1",

}

TY - JOUR

T1 - Amelanotic cutaneous melanoma

T2 - Case reports and considerations

AU - Betti, R.

AU - Vergani, R.

AU - Palvarini, M.

AU - Inselvini, E.

AU - Pazzini, C.

AU - Crosti, C.

PY - 1999

Y1 - 1999

N2 - In our study, we investigated the history of ten patients with amelanotic melanomas and considered the clinical aspect of the lesions and the difficulty in diagnosis, in order to discuss the possible delay in their diagnosis. The tumours regarded elderly patents (mean age 57.9 years), without significant difference betWeen sexes. Lower limbs were the preferential site (80%), the mean thickness was 2.9 min. We also found an average of 15.9 months of delay in diagnosis (vs 8 months in patients with pigmented melanoma). Amelanotic melanoma is easily confused with epithelial tumour or dermatitis, but when a lesion cannot be included among any usual presentations of the former, and does not respond to the routine treatment, the diagnosis of amelanotic melanoma should be taken into account. Moreover, the delay in diagnosis may contribute to the thickness of the tumour and to the poor prognosis.

AB - In our study, we investigated the history of ten patients with amelanotic melanomas and considered the clinical aspect of the lesions and the difficulty in diagnosis, in order to discuss the possible delay in their diagnosis. The tumours regarded elderly patents (mean age 57.9 years), without significant difference betWeen sexes. Lower limbs were the preferential site (80%), the mean thickness was 2.9 min. We also found an average of 15.9 months of delay in diagnosis (vs 8 months in patients with pigmented melanoma). Amelanotic melanoma is easily confused with epithelial tumour or dermatitis, but when a lesion cannot be included among any usual presentations of the former, and does not respond to the routine treatment, the diagnosis of amelanotic melanoma should be taken into account. Moreover, the delay in diagnosis may contribute to the thickness of the tumour and to the poor prognosis.

KW - Amelanotic melanoma

KW - Delayed diagnosis

UR - http://www.scopus.com/inward/record.url?scp=0033065205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033065205&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 9

EP - 20

JO - Skin Cancer

JF - Skin Cancer

SN - 0871-2549

IS - 1

ER -